Kenvue (KVUE) Stock Price, Quote, News & History | Benzinga

Kenvue Inc (KVUE) Stock Price, Quote, News & History

KVUENYSE

Trade with Public

Trade with Public

$18.95

-0.18-0.94%

At close: Sep 3, 5:00 PM EST

$18.95

N/A

After Hours: 6:47 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$19.18

Close

$18.95

Volume / Avg.

18.57M / 20.67M

Day Range

$18.84 - $19.18

52 Wk Range

14.02 - 20.82

Market Cap

$36.40B

P/E Ratio

22.51

Dividend Yield

4.39%

Exchange

NYSE

RSI

47

Short Interest

3.19%

Days to Cover

2.54

Recent Kenvue Inc. News

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11 vaccines.

Radhika Anilkumar Nadig

Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'

The Trump administration is reportedly considering an executive order on vaccines and autism as early as next week.

Namrata Sen

Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest

Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc litigation over ovarian cancer claims.

Vandana Singh

Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%

Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisition by Kimberly-Clark.

Lekha Gupta

FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder

FDA approves expanded use of Wellcovorin tablets to treat cerebral folate deficiency linked to the FOLR1 gene in adults and children.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.33B

Investing Cash Flow (TTM)

-424.00M

Financing Cash Flow (TTM)

-1.86B

Free Cash Flow (TTM)

1.91B

Capital Expenditure (TTM)

-411.00M

Net Change in Cash (TTM)

40.00M

Analyst Trends and Forecast

1

Mar

3

Apr

2

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.6

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$44.25B

PE Ratio (TTM)

22.51

PE Ratio (FWD)

15.95

PEG Ratio (TTM)

1.52

PS Ratio (TTM)

2.39

PB Ratio (TTM)

3.48

Earnings Yield % (TTM)

4.44%

Earnings Yield % (FWD)

6.27%

EV / EBITDA (TTM)

13.76

Price / EBITDA (TTM)

11.43

Price / Free Cash Flow (TTM)

19.20

Book Value / Share

$5.49

Company Debt

Total Debt

$8.48B

LT Debt

$7.07B

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$750.00M

Total Cash

$1.11B

Debt to Equity

0.82

Issuance of Debt (TTM)

-$750.00M

Repayment of Debt (TTM)

-$1.62B

Key Statistics

Open

$19.18

Close

$18.95

Volume / Avg.

18.57M / 20.67M

Day Range

$18.84 - $19.18

52 Wk Range

14.02 - 20.82

Market Cap

$36.40B

P/E Ratio

22.51

Dividend Yield

4.39%

Exchange

NYSE

RSI

47

Short Interest

3.19%

Days to Cover

2.54

About

Sector

Consumer Staples

Industry

Personal Products

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kenvue (KVUE) stock?

A

You can purchase shares of Kenvue (NYSE:KVUE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kenvue (KVUE) competitors?

A

Other companies in Kenvue’s space includes: The Estee Lauder Companies Inc (NYSE:EL), Interparfums Inc (NASDAQ:IPAR), Coty Inc (NYSE:COTY), Herbalife Ltd (NYSE:HLF) and BellRing Brands Inc (NYSE:BRBR).

Q

What is the forecast, or price target, for Kenvue (KVUE) stock?

A

Kenvue has a consensus price target of $20.91.

Q

What is the current price for Kenvue (KVUE)?

A

The stock price for Kenvue (NYSE: KVUE) is $18.95 last updated September 3, 2026 at 6:47 PM EDT.

Q

Does Kenvue (KVUE) pay a dividend?

A

There are no upcoming dividends for Kenvue.

Q

When is Kenvue (NYSE:KVUE) reporting earnings?

A

Kenvue does not have any upcoming earnings scheduled.

Q

Is Kenvue (KVUE) going to split?

A

There is no upcoming split for Kenvue.

Q

What sector and industry does Kenvue (KVUE) operate in?

A

Kenvue is in the Consumer Staples sector and Personal Products industry. They are listed on the NYSE.